Abiopharma

🔍 Grace Caroline (Director)

Company: AMN HEALTHCARE SERVICES INC (AMN)

Report Date: 2026-01-15

Detailed Transactions and Holdings:

• Acquired 5,042 shares of Common Stock (Direct)
  Date: 2026-01-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 55,996.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,495 shares of Common Stock at $19.55 per share (Direct)
  Date: 2026-01-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 54,501.00 | transaction_form_type: 4 | Footnotes: F3
• Acquired 10,664 shares of Common Stock (Direct)
  Date: 2026-01-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 65,165.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,713 shares of Common Stock at $19.55 per share (Direct)
  Date: 2026-01-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 62,452.00 | transaction_form_type: 4 | Footnotes: F3
• Acquired 25,425 shares of Common Stock (Direct)
  Date: 2026-01-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 87,877.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 6,191 shares of Common Stock at $19.55 per share (Direct)
  Date: 2026-01-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 81,686.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 5,042 shares of Restricted Stock Units (Derivative)
  Date: 2026-01-15 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F4, F5, F6
• Sold 10,664 shares of Restricted Stock Units (Derivative)
  Date: 2026-01-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 10,988.00 | transaction_form_type: 4 | Footnotes: F4, F7, F6
• Sold 25,425 shares of Restricted Stock Units (Derivative)
  Date: 2026-01-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 51,623.00 | transaction_form_type: 4 | Footnotes: F4, F8, F6
• Acquired 129,923 shares of Restricted Stock Units (Derivative)
  Date: 2026-01-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 129,923.00 | transaction_form_type: 4 | Footnotes: F9, F10, F6

Footnotes:

• F1: Common stock acquired on the vesting of Restricted Stock Units.
• F2: Includes 607 shares of AMN Common Stock purchased pursuant to the AMN Healthcare Employee Stock Purchase Plan ("ESPP") on March 31, 2025.
• F3: Number of shares withheld for tax purposes.
• F4: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.
• F5: The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.
• F6: Restricted Stock Units do not have an expiration date.
• F7: The Restricted Stock Units identified in this row were granted on January 15, 2024 and vest in three tranches on the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.
• F8: The Restricted Stock Units set forth in this row were granted on January 15, 2025 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.
• F9: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.
• F10: The Restricted Stock Units set forth in this row were granted on January 15, 2026 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.